Should We Really Still Be Using Creatinine in the Critical Care Setting?
- PMID: 37410991
- PMCID: PMC10564348
- DOI: 10.2215/CJN.0000000000000225
Should We Really Still Be Using Creatinine in the Critical Care Setting?
Conflict of interest statement
T.K. Chen reports employment with San Francisco VA Health Care System and research funding from NIH/NIDDK and Yale University. M.G. Shlipak reports research funding from Bayer Pharmaceuticals; honoraria from AstraZeneca, Bayer, and Boehringer Ingelheim; patents or royalties from Kidney Health Monitoring in Hypertension Patients; advisory or leadership role as Board Member for Northern California Institute for Research and Education; role on the Editorial Boards of the
Comment on
-
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness.Clin J Am Soc Nephrol. 2023 Aug 1;18(8):997-1005. doi: 10.2215/CJN.0000000000000203. Epub 2023 May 31. Clin J Am Soc Nephrol. 2023. PMID: 37256861 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources